Last Close
Apr 09  •  04:00PM ET
0.6201
Dollar change
-0.0175
Percentage change
-2.74
%
Apr 08, 4:10 PMNexgel revises financing plan for Celularity transaction, no longer using previously announced securities purchase agreement
Index
-
P/E
-
EPS (ttm)
-0.38
Insider Own
16.23%
Shs Outstand
8.14M
Perf Week
-0.74%
Market Cap
6.86M
Forward P/E
2.70
EPS next Y
0.23
Insider Trans
-0.77%
Shs Float
7.10M
Perf Month
-34.85%
Enterprise Value
9.32M
PEG
-
EPS next Q
-
Inst Own
7.11%
Perf Quarter
-63.95%
Income
-3.00M
P/S
0.60
EPS this Y
84.21%
Inst Trans
1.85%
Perf Half Y
-75.78%
Sales
11.42M
P/B
1.13
EPS next Y
483.33%
ROA
-27.98%
Perf YTD
-61.48%
Book/sh
0.55
P/C
6.47
EPS next 5Y
-
ROE
-58.74%
52W High
3.02 -79.46%
Perf Year
-76.69%
Cash/sh
0.10
P/FCF
-
EPS past 3/5Y
23.44% -77.47%
ROIC
-42.41%
52W Low
0.58 7.43%
Perf 3Y
-55.07%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
77.33% 76.12%
Gross Margin
38.37%
Volatility
9.92% 13.67%
Perf 5Y
-
Dividend TTM
-
EV/Sales
0.82
EPS Y/Y TTM
24.70%
Oper. Margin
-29.35%
ATR (14)
0.09
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.75
Sales Y/Y TTM
31.46%
Profit Margin
-26.27%
RSI (14)
34.64
Dividend Gr. 3/5Y
- -
Current Ratio
1.47
EPS Q/Q
-2.32%
SMA20
-12.13%
Beta
0.85
Payout
-
Debt/Eq
0.69
Sales Q/Q
-8.06%
SMA50
-38.78%
Rel Volume
0.56
Prev Close
0.64
Employees
19
LT Debt/Eq
0.59
SMA200
-67.41%
Avg Volume
265.39K
Price
0.62
IPO
Dec 22, 2021
Option/Short
No / Yes
Trades
Volume
147,423
Change
-2.74%
Apr-08-26 09:00PM
04:05PM
Mar-31-26 04:12PM
Mar-25-26 09:00AM
Mar-12-26 08:45AM
08:45AM Loading…
Mar-10-26 08:45AM
08:30AM
Feb-10-26 09:00AM
Dec-16-25 08:00AM
Dec-11-25 08:00AM
Nov-12-25 12:00AM
Nov-11-25 04:10PM
Nov-03-25 08:00AM
Oct-09-25 08:00AM
Aug-13-25 03:14AM
04:05PM Loading…
Aug-12-25 04:05PM
Aug-06-25 08:00AM
Aug-05-25 08:00AM
Aug-01-25 08:00AM
Jul-14-25 09:00AM
May-21-25 09:00AM
May-13-25 04:05PM
May-09-25 09:00AM
Apr-07-25 09:00AM
Mar-24-25 05:41PM
04:05PM
Mar-21-25 09:00AM
Mar-19-25 09:00AM
Mar-13-25 09:00AM
Feb-13-25 09:00AM
09:00AM Loading…
Jan-22-25 09:00AM
Jan-02-25 09:00AM
Dec-06-24 08:30AM
Nov-21-24 09:00AM
Nov-13-24 04:40PM
Nov-11-24 05:35PM
09:00AM
Oct-11-24 09:05AM
09:00AM
Oct-10-24 09:00AM
Oct-04-24 09:00AM
Sep-18-24 09:00AM
Aug-14-24 04:25PM
Aug-12-24 09:15AM
09:00AM
Jul-18-24 09:15AM
Jul-08-24 04:05PM
Jun-27-24 09:00AM
Jun-11-24 08:40AM
May-16-24 09:00AM
May-13-24 08:53PM
04:05PM
May-09-24 08:00AM
May-06-24 04:05PM
Apr-29-24 09:00AM
Apr-18-24 08:00AM
Apr-02-24 10:28AM
Apr-01-24 12:52PM
07:50AM
Mar-27-24 09:00AM
Mar-21-24 09:00AM
Mar-11-24 11:00AM
Mar-04-24 08:30AM
Feb-21-24 04:05PM
Jan-18-24 09:00AM
Jan-09-24 08:30AM
Dec-11-23 08:00AM
Dec-05-23 08:00AM
Nov-20-23 10:00AM
Nov-16-23 06:35AM
Nov-13-23 04:05PM
Nov-02-23 09:00AM
Oct-30-23 08:00AM
Sep-26-23 09:49AM
Sep-15-23 11:02AM
Aug-14-23 04:05PM
Aug-11-23 07:01AM
Aug-10-23 06:24AM
Aug-09-23 06:26AM
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-04-23 07:14AM
Aug-03-23 07:15AM
Aug-02-23 09:00AM
07:52AM
Aug-01-23 06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
Jul-24-23 07:12AM
Jul-21-23 07:23AM
Jul-20-23 06:55AM
Jul-19-23 09:10AM
07:10AM
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
Jul-13-23 07:02AM
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It operates through the NexGel and CGN segments. The NexGel segment consists of the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. The CGN segment consists of the CGN JV used for the company's converting and packaging business, which is based in Granbury, Texas. The company was founded on January 13, 2009, and is headquartered in Langhorne, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Levy Adam R.Chief Executive OfficerDec 22 '25Sale1.616,0009,661361,692Dec 29 08:47 AM
Levy Adam R.Chief Executive OfficerDec 24 '25Sale1.574,0006,286357,692Dec 29 08:47 AM
Levy Adam R.OfficerDec 22 '25Proposed Sale1.6410,00016,400Dec 22 11:24 AM
Levy Adam R.Chief Executive OfficerNov 06 '25Sale2.524,00010,084367,692Nov 07 08:00 PM
Henry Scott RobertDirectorOct 03 '25Sale2.557,17518,298113,356Oct 06 08:00 PM
Henry Scott RobertDirectorOct 02 '25Sale2.508252,062120,531Oct 06 08:00 PM
Levy Adam R.Chief Executive OfficerOct 03 '25Sale2.552,4006,119371,692Oct 06 08:00 PM
Levy Adam R.Chief Executive OfficerOct 02 '25Sale2.501,6004,000374,092Oct 06 08:00 PM
Levy Adam R.OfficerOct 02 '25Proposed Sale2.5016,00040,000Oct 02 04:57 PM
Henry Scott RobertDirectorSep 25 '25Sale2.367,69718,149121,356Sep 29 08:00 PM
Henry Scott RobertDirectorSep 25 '25Proposed Sale3.0535,515108,451Sep 25 11:55 AM
Levy Adam R.Chief Executive OfficerAug 28 '25Sale2.474,0009,896358,284Aug 29 08:00 PM
Levy Adam R.OfficerAug 28 '25Proposed Sale2.454,0009,800Aug 28 01:54 PM
Henry Scott RobertDirectorJun 13 '25Sale2.573,0007,704129,053Jun 16 08:00 PM
Levy Adam R.Chief Executive OfficerJun 11 '25Sale2.392,0004,780362,284Jun 11 08:00 PM
Levy Adam R.Chief Executive OfficerJun 09 '25Sale2.332,0004,659364,284Jun 11 08:00 PM
Levy Adam R.Chief Executive OfficerJun 05 '25Sale2.321,0002,323366,284Jun 06 08:00 PM
Levy Adam R.Chief Executive OfficerJun 04 '25Sale2.291,0002,290367,284Jun 06 08:00 PM
Levy Adam R.Chief Executive OfficerMay 30 '25Sale2.221,0002,220368,284Jun 02 08:00 PM
Levy Adam R.Chief Executive OfficerMay 16 '25Sale2.581,0002,575369,284May 20 08:00 PM
Levy Adam R.OfficerMay 16 '25Proposed Sale2.378,00018,960May 16 10:41 AM
Henry Scott RobertDirectorMay 12 '25Sale2.693,0008,062132,053May 13 08:00 PM
Henry Scott RobertDirectorApr 10 '25Sale2.613,0007,825135,053Apr 14 05:00 PM
Henry Scott RobertDirectorApr 10 '25Proposed Sale2.609,00023,400Apr 10 10:37 AM